Cargando…

SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin’s Lymphoma

Background. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is the most transmissible ß-coronavirus in history, affecting all population groups. Immunocompromised patients, particularly cancer patients, have been highlighted as a reservoir to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villaseñor-Echavarri, Rodrigo, Gomez-Romero, Laura, Martin-Onraet, Alexandra, Herrera, Luis A., Escobar-Arrazola, Marco A., Ramirez-Vega, Oscar A., Barrientos-Flores, Corazón, Mendoza-Vargas, Alfredo, Hidalgo-Miranda, Alfredo, Vilar-Compte, Diana, Cedro-Tanda, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962578/ https://www.ncbi.nlm.nih.gov/pubmed/36851588 http://dx.doi.org/10.3390/v15020377

Ejemplares similares

Use of remdesivir for COVID-19 in patients with hematologic cancer
por: Martin-Onraët, Alexandra, et al.
Publicado: (2022)

1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico
por: Villaseñor-Echavarri, Rodrigo, et al.
Publicado: (2022)

Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
por: Beltrán-Anaya, Fredy O., et al.
Publicado: (2016)

Analytical Performances of the COVISTIX(TM) Antigen Rapid Test for SARS-CoV-2 Detection in an Unselected Population (All-Comers)
por: Garcia-Cardenas, Francisco, et al.
Publicado: (2022)

End-point RT-PCR based on a conservation landscape for SARS-COV-2 detection
por: Cruz-Rangel, Armando, et al.
Publicado: (2022)

Infectious Norovirus Is Chronically Shed by Immunocompromised Pediatric Hosts
por: Davis, Amy, et al.
Publicado: (2020)

Long-term Shedding of Influenza A Virus in Stool of Immunocompromised Child
por: Pinsky, Benjamin A., et al.
Publicado: (2010)

The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City
por: Cedro-Tanda, Alberto, et al.
Publicado: (2021)

Pathogenicity and Viral Shedding of MERS-CoV in Immunocompromised Rhesus Macaques
por: Prescott, Joseph, et al.
Publicado: (2018)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

278. Immunocompromised Patients with Prolonged Viral Shedding of SARS-COV-2
por: Tarabay, Jessica, et al.
Publicado: (2021)

Prolonged Influenza Virus Shedding and Emergence of Antiviral Resistance in Immunocompromised Patients and Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2013)

Clinical and Virological Features of SARS-CoV-2 Variants during the Four Waves of the Pandemic in the Mexican Southeast
por: Baeza-Flores, Guadalupe del Carmen, et al.
Publicado: (2023)

Functional Integrity and Gene Expression Profiles of Human Cord Blood‐Derived Hematopoietic Stem and Progenitor Cells Generated In Vitro
por: Dircio‐Maldonado, Roberto, et al.
Publicado: (2018)

Prevalence of latent tuberculosis in patients with hematological neoplasms in a cancer referral hospital in Mexico City
por: Osorio-López, Erick Antonio, et al.
Publicado: (2021)

SARS-CoV-2 positivity rates in asymptomatic workers at a cancer referral center in Mexico City: A prospective observational study in the context of adapting hospitals back to regular practice
por: Noverón, Nancy Reynoso, et al.
Publicado: (2021)

SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
por: Kaila, Ville, et al.
Publicado: (2021)

The Human Papillomavirus (HPV) E1 protein regulates the expression of cellular genes involved in immune response
por: Castro-Muñoz, Leonardo Josué, et al.
Publicado: (2019)

Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient
por: Shoji, Kosuke, et al.
Publicado: (2022)

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
por: Avanzato, Victoria A., et al.
Publicado: (2020)

Influenza in patients with cancer after 2009 pandemic AH1N1: An 8‐year follow‐up study in Mexico
por: Ángeles‐Sistac, Diego, et al.
Publicado: (2019)

Nocardiosis in Immunocompromised Patients on Alternative Pneumocystis Prophylaxis
por: Puing, Alfredo G., et al.
Publicado: (2021)

Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report
por: Niyonkuru, Melissa, et al.
Publicado: (2021)

Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient
por: Julian, Katherine, et al.
Publicado: (2021)

Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma
por: Borges, Vítor, et al.
Publicado: (2021)

Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs
por: Hong, Minki, et al.
Publicado: (2013)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

Identification of Multiple Novel Protein Biomarkers Shed by Human Serous Ovarian Tumors into the Blood of Immunocompromised Mice and Verified in Patient Sera
por: Beer, Lynn A., et al.
Publicado: (2013)

Prolonged shedding of SARS-CoV-2 at high viral load amongst hospitalised immunocompromised persons living with HIV in South Africa
por: Meiring, S., et al.
Publicado: (2022)

A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype
por: Cedro-Tanda, Alberto, et al.
Publicado: (2020)

FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patients
por: Ríos-Romero, Magdalena, et al.
Publicado: (2020)

Characteristics and risk factors of prolonged viable virus shedding in immunocompromised patients with COVID-19: a prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City
por: Cedro-Tanda, Alberto, et al.
Publicado: (2022)

775 Nosocomial Influenza (NI) in cancer patients during a high activity season in Mexico City
por: Vilar-Compte, Diana, et al.
Publicado: (2014)

Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection
por: Arriaga-Canon, Cristian, et al.
Publicado: (2022)

2632. Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era
por: Kanai, Osamu, et al.
Publicado: (2023)

Imaging evaluation of phylodes tumor at the National Institute of Cancerology: 86 patient series
por: Villafañe, Nestor, et al.
Publicado: (2007)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

Cave diving for a diagnosis: Disseminated histoplasmosis in the immunocompromised
por: Mirza, Abu-Sayeef, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g3rst3ggb7ojpq980qt7rdei04